Gilead Sciences reported $62.87B in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acorda Therapeutics ACOR:US $ 406.31M 17.83M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
ALKERMES ALKS:US $ 1957.42M 20.43M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amgen AMGN:US $ 59294M 98M
Biogen BIIB:US $ 25081.4M 1467M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Coherus Biosciences CHRS:US $ 546M 47.38M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 8904500M 64400M
Glaxosmithkline GSK:US $ 89045M 644M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Moderna Inc MRNA:US 26.04B 1.57B
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Novartis NOVN:VX SF 122910M 2308M
Ptc Therapeutics PTCT:US $ 1804.06M 4.47M
Puma Biotechnology PBYI:US $ 193.65M 7.03M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
United Therapeutics UTHR:US $ 5543.3M 183.5M
Vertex Pharmaceuticals VRTX:US $ 15582.2M 1326.1M
YTE INCY:US $ 5319.04M 264.81M